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Can cognitive insight predict symptom
remission in a first episode psychosis
cohort?
Jennifer A. O’Connor1,2*, Lyn Ellett2, Olesya Ajnakina1, Tabea Schoeler1, Anna Kollliakou3, Antonella Trotta1,
Benjamin D. Wiffen1, Aurora M. Falcone1, Marta Di Forti1, Robin M. Murray1, Sagnik Bhattacharyya1
and Anthony S. David1
Abstract
Background: The outcome of first episode psychosis (FEP) is highly variable and difficult to predict. Cognitive
insight measured at illness onset has previously been found to predict psychopathology 12-months later. The aims
of this study were to examine whether the prospective relationship between cognitive insight and symptom
severity is evident at four-years following FEP and to examine some psychological correlates of cognitive insight.
Methods: FEP participants (n = 90) completed the Beck Cognitive Insight Scale (BCIS) at illness onset, and
associations between BCIS scores with symptom severity outcomes (4-years after FEP) were assessed. The BCIS
scales (self-reflectiveness and self-certainty) were examined as a composite score, and individually compared to other
cognitive measures (IQ and jumping to conclusions (JTC) bias).
Results: Regression analyses revealed that the cognitive insight composite did not predict 4-year symptom
remission in this study while the self-reflection subscale of the BCIS predicted severity of symptoms at 4-years. Self-
certainty items of the BCIS were not associated with symptom severity. Significant correlations between the JTC
bias, self-certainty and IQ were found, but self-reflection did not correlate with these other cognitive measures.
Conclusions: Self-reflective capacity is a more relevant and independent cognitive construct than self-certainty for
predicting prospective symptom severity in psychosis. Improving self-reflection may be a useful target for early
intervention research.
Background
The study of higher-order thinking in psychosis popula-
tions has been examined using various cognitive con-
structs. Self-reflective capacity is a meta-cognitive
construct defined as the ability to be accurately intro-
spective, and recognise one’s own subjective fallibility
[1]. It has been suggested that impaired self-reflection
may lead to poor sensory and narrative integration of ex-
perience, increasing the risk of psychiatric symptoms [2].
A different but related construct relevant to psychosis
research is ‘over-confidence in judgement’, which is
thought to manifest behaviourally in reasoning biases
such as an early acceptance of incorrect ideas and failure
to consider alternatives, and is often found associated
with delusional beliefs [3–5]. Beck and colleagues sug-
gest that self-reflection and confidence in judgement are
related though psychometrically distinct concepts, such
that a high level of self-certainty might diminish one’s
ability or willingness to be introspective [6]. Likewise a
sound self-reflective capacity may enable one to redress
reasoning biases [6].
The Beck Cognitive Insight Scale (BCIS) [7] exam-
ines these two theoretically driven and empirically de-
rived factors: self-certainty, which assesses over-
confidence and certainty about being right (e.g. ‘I
know better than anyone else what my problems are’),
and self-reflectiveness, which assesses willingness to
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accept fallibility and external feedback, as well as
recognising dysfunctional reasoning style (e.g. ‘Some of
the ideas I was certain were true turned out to be
false’). A composite index can be calculated by sub-
tracting self-certainty from self-reflective scores. Thus
high self-reflectiveness and low self-certainty is the
formula for good ‘cognitive insight’ [7].
It is proposed in this study, that limited cognitive
insight increases one’s risk for experiencing enduring
psychotic symptoms over time. Earlier analyses from our
research group found that cognitive insight at first-
episode psychosis (FEP) is a predictor of overall symp-
tom severity at 12-month follow-up [8]. This finding
supports other research which found that cognitive
insight is cross-sectionally associated with symptom se-
verity across a range of positive symptoms in psychosis
[9–12]. Until now, the question of whether cognitive
insight prospectively predicts symptom outcome beyond
12 months has not been examined.
Understanding the individual BCIS scales within a
broader neuro-cognitive framework is also important,
and the question of how the individual subscales under-
lying cognitive insight (self-reflection and self-certainty)
operate in psychosis populations still requires scrutiny.
While the general consensus is that individuals with
psychosis show lower-levels of self-reflection and
greater-levels of self-certainty [9, 11, 13, 14] there are
studies that report contradictory findings, with some
failing to show a significant difference on BCIS subscale
scores between people with schizophrenia and healthy
controls [15, 16]. Furthermore, Köther et al. [17] demon-
strated that self-certainty ratings were actually lower for
people with schizophrenia. Elucidating the patterns of
association that the BCIS scales have with other cogni-
tive variables might help to explain how cognitive insight
is relevant to clinical outcome in psychosis.
While our research group previously found cognitive
insight to be distinct in its predictive value from other
neuropsychological variables such as executive function,
IQ and clinical insight (i.e. one’s awareness of their own
psychosis) [18, 19] we did not explore how the BCIS
measure relates to other ‘reasoning bias’ type cognitive
constructs which are often examined in psychosis re-
search. One such construct is the ‘jumping to conclu-
sions (JTC)’ data-gathering bias [20]. Whilst the
relationship between JTC and psychosis is well-
established [4, 21, 22], it is still unclear whether JTC be-
haviour is an accurate measure of ‘overconfidence in
judgement’ or measures nothing more than hasty deci-
sion making [23]. For this reason, understanding how
this data gathering bias correlates with a direct measure
of over-confidence (i.e. BCIS self-certainty) is of theoret-
ical interest and may help broaden our knowledge of
how self-certainty operates in FEP. It is also important
to consider IQ when studying the correlates of these
higher-order constructs given the relevance of neuro-
psychological aspects of cognition to prognosis in psych-
osis [24, 25].
In light of the current gaps in the literature as de-
scribed, the aim of the current study was to examine
whether cognitive insight can predict four year symptom
severity in an FEP sample previously described [8] and
explore how the underlying components of cognitive
insight (self-certainty and self-reflection) are associated
with other cognitive factors (IQ and JTC).
Methods
Participants
First episode psychosis patients (n = 111) were recruited
as part of the National Institute of Health Research
(NIHR) and Biomedical Research Centre (BRC), Genet-
ics and Psychosis study. Selection criteria required par-
ticipants to be aged 18–65 years, who met DSM-IV
criteria for psychosis, and presented to the selected bor-
oughs in South London adult mental health services
(identified through examination of the clinical notes of
new psychiatric admissions and consultation with clin-
ical teams). Further inclusion criteria were applied: con-
tact with psychiatric services for psychosis ≤6 months;
fluent English speaker; psychosis identified as having a
non-organic cause (e.g. differential diagnoses such as
medically induced psychosis i.e. deliriums, a history of
head injury or neurological condition were exclusions).
All those patients identified as eligible, were approached
as soon as possible and invited to take part in the study.
Research diagnoses were provided by qualified psychia-
trists subject to inter-rater reliability checks (Intra class
correlation = .97) using the Operational Criteria for stud-
ies of psychotic illness (OPCRIT) [26].
Measures
Demographic data were collected from self-report, sup-
plemented by clinical records, at study entry.
Cognitive measures
Cognitive insight was measured using the Beck Cogni-
tive Insight Scale: BCIS [7]. This is a 15 item self-report
scale, with items rated from ‘do not agree at all’ to ‘agree
completely’. There are two subscales which measure par-
ticipant endorsement of: ‘self-reflectiveness’ (nine items,
range 9 to 63), and ‘self-certainty’ (six items, range 6 to
42). A cognitive insight score was derived by deducting
the BCIS self-certainty scale item total from the BCIS
self-reflective scale item total. Consistent with our previ-
ous research [8], each BCIS item was rated on 7- point
scale instead of the original 4-point scale, to increase the
precision of this measure [27]. Confirmatory factor ana-
lysis conducted in this study sample suggests that factor
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loadings for both constructs were equivalent to the ori-
ginal item loadings [7], and the two factor model
reached statistical significance (t-ratio >1.96) [28]. Cron-
bach’s α for the self-certainty and self-reflective scale in
this study was 0.76 and 0.71 respectively, higher than
the consistencies achieved in the original BCIS publica-
tion paper [7].
The ‘Jumping to Conclusions’ or JTC bias, was mea-
sured by the behavioural response to a probabilistic rea-
soning paradigm called ‘The Beads Task’ [29]; in the
version used for this study, participants were shown two
jars that contain coloured beads (orange or black). Each
jar contained beads in a different proportion, e.g. one jar
contains 85 black and 15 orange beads, and the other jar
contains the reverse proportion. Participants were in-
formed of and shown the coloured bead proportions, be-
fore the containers were removed from view.
Participants were then told that each jar (either the jar
containing mainly orange beads or that containing
mainly black beads) has the same probability of being
chosen by the researcher (50:50) and that beads will be
extracted from the selected jar and shown to partici-
pants one at a time. It was the participant’s task to de-
cide from which of the two jars the beads were being
taken; the mainly orange or the mainly black jar. They
were told that they should only decide when they are
certain. We adopted the ‘two or less draw to decision
threshold’ measure to identify JTC bias, as this measure
has been shown to be most reliably associated with
delusions [30, 31]. A tendency to ‘Jump to Conclusions’
was operationally defined as the respondent making a de-
cision after two beads or fewer, as this threshold has been
used in other FEP studies [32, 33]. To estimate IQ, a short
version of the Wechsler Adult Intelligence Scale -Third
Edition: WAIS III [34] was administered and included the
following subtests: Information, Digit Span, Block Design,
Matrix Reasoning and Digit Symbol Coding. These par-
ticular subtests were chosen because they index a wide
range of cognitive abilities, including all relevant IQ do-
mains. These scores were averaged within their domain
and multiplied by the total number of WAIS III subtests
in each domain to approximate an individual IQ score;
using short-forms of WAIS is common in psychosis re-
search to estimate full scale IQ [35–38].
Psychopathology
The Positive and Negative Syndrome Scale (PANSS) [39]
was used to rate symptoms at study entry. Only the
positive and negative scales were examined in this study.
Each item is scored on a scale of 1 to 7: absent, minimal,
mild, moderate, moderate severe, severe and extreme. A
score of 4 (moderate) or higher indicates the presence of
clinical psychopathology. Item ratings were completed
through interview with participants and by collecting
collateral information from healthcare workers based on
7 days prior to assessment. Inter-rater agreement coeffi-
cients for rating pairs (n = 22) were calculated using a
Spearman-Brown formula (agreement amongst multiple
observers corrected for number of observers). Mean
level of agreement was r = 0.814, which is above conven-
tionally accepted thresholds for adequate inter-rater
agreement [40].
The Global Assessment of Functioning (GAF) [41] was
used to measure overall illness severity at study entry
and at follow-up. The GAF is a widely used observer-
rated instrument to determine clinical and functional
status on a scale from 1 to 100. We measured symptom
experience (GAF-S) separately to functional disability
(GAF-F). Making this distinction between these two re-
covery types on the GAF has been shown to improve the
psychometric properties of this measure [42]. Informa-
tion for GAF-S ratings were derived from “any source,
such as direct interview of the patient, a reliable inform-
ant, or a case record” [41] (p767). In this study, clinical
notes were used or when possible, GAF-S was rated fol-
lowing face to face interview. Raters were subject to
inter-rater reliability checks, achieving excellent intra-
class correlations when rating GAF-S from clinical re-
cords (ICC > 0.90) [43]. Further, GAF-S scores collected
from clinical records compared to GAF-S scored via face
to face interview showed high comparability (ICC = .81)
[43].
Design and procedure
The study used a within subject longitudinal design to
analyse relationships between cognitive insight collected
at the first onset of psychosis and GAF-S collected at 4-
year follow-up. The initial sample of interest (n = 111)
consisted only of participants who completed all cogni-
tive measures of interest to this study at baseline (87% of
total sample evaluated at O’Connor et al. 12 month
follow-up study [8]). Baseline variables (GAF-S, JTC, IQ,
PANSS, demographic factors and diagnoses) were ana-
lysed as possible covariates, and to characterise the pa-
tient sample. Participants completed measures at follow-
up with an attrition rate of 18.9% (see Fig. 1 for details).
The majority of this sample (95%) formed part of the
12 month follow-up in our previous study [8]. The aver-
age follow-up time was 49 months, or just over four
years post FEP (sd = 11.5, range 27–86 months).
Data analysis
Hierarchical multiple regression was conducted with
GAF symptoms at four-years as the dependent variable
and cognitive insight (BCIS composite score) as the pre-
dictor variable. Analyses of Pearson’s and point bi-serial
correlations were conducted to examine relationships
between covariates and the dependent variable (GAF-S
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at 4 year follow-up); covariates which correlated highly
with the outcome measure (p < .01 and of greater mag-
nitude than r = .25) were entered into subsequent regres-
sion modelling [44], before cognitive insight was entered
at step 2. Correlation analyses enabled the investigation
of relationships between the BCIS scales and other cog-
nitive variables (IQ and JTC bias).
Results
Descriptive baseline data
Table 1 describes the demographic, clinical and cognitive
characteristics of this sample that completed follow-up
at four-years after FEP (n = 90). Participants were classi-
fied into eight different diagnostic categories according
to the DSM IV. The most common diagnosis was schi-
zophreniform disorder (28.8%) and the majority of par-
ticipants (57.7%) were classified as having a non-
affective psychosis. In terms of symptom severity, the
mean PANSS positive and negative symptom subscale
scores suggest that the average participant was ‘mildly
unwell’ at baseline assessment. In terms of cognitive de-
scriptive data, other than those reported in Table 1, the
self-reflective scale (SR) and the self-certainty scale (SC)
scales were negatively correlated (r = −.253). The mean
IQ score was in the low-average range commensurate
with previous FEP findings [45]. Nearly half the sample
(45%) showed a JTC bias according to a <2 beads thresh-
old, which is also consistent with previous FEP findings
[32].
Follow-up data
There were no significant differences between those who
were traceable for 4-year follow-up assessment (n = 90)
versus those who had become untraceable at follow-
up (n = 21), with the exception of baseline GAF-S
scores, in that those who were untraceable at follow-
up had significantly more psychopathology at baseline:
t (109) = −2.341, p = 0.012. Compared to baseline, GAF
symptom severity was significantly lower at 4-year
follow-up (t (87) = −4.816, p < 0.001 respectively). A 4-
years, the cohort mean GAF symptom score was above
remission thresholds for FEP (>59) [46].
Main analysis
Correlation analysis was conducted to determine which
baseline predictors should be entered into predictor
models. Only variables that correlated significantly with
GAF symptom outcome at 4 year follow-up as outlined
above were entered into subsequent regression models.
The GAF Time-0 symptom measure did not correlate
with GAF symptoms as 4 year follow-up. GAF symptom
scores at four-year follow-up were significantly corre-
lated with baseline negative symptoms (r = −.320) and
diagnosis (rpb = .294) such that less severe negative
symptoms and an affective diagnosis at FEP onset was
associated with decreased psychopathology at 4-year
follow-up. Therefore these variables were entered into
the hierarchical regression at step 1, and cognitive
insight was entered at step 2. Overall, the model was
Fig. 1 Flowchart indicating follow-up methodology and attrition rate
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significant and negative symptoms, diagnosis and cogni-
tive insight accounted for approximately 15% of variance
in symptom outcome [F(3,79) = 4.797, p = 0.002]. How-
ever, cognitive insight uniquely accounted for just 0.6%
of variance in symptom outcome, which was not a sig-
nificant individual contribution to the model [F (3, 79)
= .585 p = 0.447 R2 = .148, adjusted R2 = .115)].
Post hoc analysis of the BCIS scales individually re-
vealed that self-reflectiveness was significantly corre-
lated with symptom outcome at 4-years such that
greater ability to self-reflect was associated with less
severe symptoms prospectively (r = .25), although not
cross-sectionally, at baseline (r = −.09). Conversely,
self-certainty did not correlate with symptom outcome
at 4-years (r = .021) although its relationship with
symptoms cross-sectionally at baseline was nearing
significance (r = −.18, p = 0.08).
The two BCIS subscales were entered separately in the
regression model to identify unique contributions of
self-reflectivity and self-certainty on symptom outcome
at 4 years. Overall, the model was significant (F (4, 78)
=5.258, p = 0.046), and by entering the BCIS subscales
separately, an increase in 6.5% of variance in symptom
outcome was explained (adjusted R2 = .172). Higher
scores on the self-reflectiveness sub-scale predicted sig-
nificantly higher GAF-S scores (i.e. less severe psycho-
pathology) at Time 2 follow-up (t (78) =2.324, p = .023).
The self-certainty sub-scale did not contribute signifi-
cantly to the variance (t (78) =1.57, p = .199). Table 2 re-
ports the unique contribution of each variable entered
into the regression model.
In summary, analyses of the BCIS scales individually
revealed that self-reflectiveness was significantly corre-
lated with symptom outcome prospectively. The self-
certainty subscale was not associated with later symptom
outcome, although its relationship with symptoms cross-
sectionally at baseline approached significance (higher
self-certainty related to greater concurrent symptom
severity).
Finally, in terms of the BCIS subscales’ relationship
to other cognitive variables, the self-certainty items
had a significant, though weak association with the
JTC bias (r = −.258) and IQ (r = −.313) such that
higher self-certainty was associated with a tendency
to jump to conclusions, and lower IQ. Neither the
JTC measure, nor IQ was significantly correlated with
the BCIS self-reflective scale (r = .029, and r = .033
respectively).
Discussion
Cognitive insight (as measured by the BCIS compos-
ite score) did not predict symptom severity at four
years post FEP, but the self-reflective sub-scale did.
Participants who endorsed highly self-reflective be-
haviour, i.e. greater agreement with scale items such
as, “some of my experiences that have seemed very
real may have been due to my imagination”, had
fewer and less severe psychopathological symptoms
Table 1 Sample Characteristics (N = 90)
Demographic characteristics
Age, years: Mean (sd)
29 (9.1)
Gender 62% male
Ethnicity (n)
White British 24
Black African 23
Black Caribbean 15
White European 8
Mixed Race 9
Asian 7
Other 4
Clinical Characteristics
Diagnosis (n)
Schizophreniform disorder 26
Manic episode with psychosis 16
Schizophrenia 13
Psychosis not otherwise specified 12
Major depression with psychotic features 10
Schizoaffective disorder depressed 8
Schizoaffective disorder bi-polar 4
Delusional disorder 1
PANSS Mean (sd)
Positive symptoms 14 (5.8)
Negative symptoms 15 (6.4)
Cognitive characteristics
BCIS Mean (sd)
Composite Index 14.33 (14.05)
Self-reflection 38.40 (9.72)
Self-certainty 24.07 (7.97)
IQ: Mean (sd) 90.39 (15.35)
JTCa 4.94 (5.30)
aDescriptive data represents draws to decisions on the Beads Task
Table 2 Hierarchical regression to predict symptom severity at
four-year follow up
Std β T p
Time 0 negative symptoms −0.247 −2.356 0.021
Diagnoses a 0.247 2.378 0.020
BCIS self-reflective scale 0.245 2.324 0.023
BCIS self-certainty scale 0.167 1.577 0.119
aaffective vs. non-affective psychosis
O’Connor et al. BMC Psychiatry  (2017) 17:54 Page 5 of 8
at four-years after psychosis onset, compared to
those individuals who did not endorse these items.
Direct and indirect measures relating to confidence
in judgement (BCIS self-certainty scale and JTC bias)
did not contribute to symptom outcome, though
these factors correlated significantly with each other,
and IQ.
These findings contradict some previous studies,
which found that the correlation between the combined
cognitive insight construct and symptom outcome is
stronger than that between individual subscales and
symptom outcome [8, 9, 47]. However, previous studies
have only examined the cross-sectional and short-term
prospective relationships between the cognitive insight
and symptom outcome and this is the first study to
examine these relationships in the medium-term (four
years) after FEP. This suggests a complex longitudinal
relationship between the BCIS and clinical status, such
that aspects of the BCIS measuring meta-cognitive
thinking (self-reflective items) have a more prospective
relationship to symptom experience, whereas those
items indexing ‘confidence in judgement’ (self-certainty
items) tend to correlate more highly to concurrent
symptoms.
The converging associations between JTC, self-
certainty and IQ support a growing body of evidence
that reasoning processes are underpinned by general in-
tellectual functions [48, 49]. For instance, the literature
suggests that schizophrenia and delusional prone partici-
pants tend to show ‘overconfident judgement’ in relation
to their own objective ‘errors’, but they do not show the
same level of conviction for their correct responses on
tasks (see Balzan et al. for a review [23]). The association
found between the JTC and BCIS self-certainty scale is
also relevant to contention in the field as to whether the
JTC beads task is measuring more than hasty decision
making [23]. Our findings tentatively support the notion
that the JTC Beads task is perhaps tapping into the same
‘confidence in judgement’ factor as the BCIS self-
certainty scale.
Our, results also suggest that self-reflective aspects of
thinking are unrelated to other measured cognitive
constructs (JTC or IQ) consistent with reports from re-
cent meta-analyses, that the BCIS self-reflective scale
had fewer neuropsychological correlates than the self-
certainty scale [49]. By virtue of its lack of correlation
with neuropsychological function, poor self-reflective
capacity may be more amenable to change through psy-
chological support. Indeed, psycho-social interventions
have been shown to change participant endorsement of
the self-reflective scale items, but not self-certainty
items [9, 50, 51].
It would be valuable to know whether self-reflection
can predict the severity of some specific psychotic
symptoms more than others (i.e. hallucinations vs. de-
lusions). Understanding this would be particularly in-
formative, given recent calls for the development of
symptom-specific interventions in psychosis [52]. In-
deed one previous CBT for psychosis intervention
found that higher endorsement of the BCIS self-
reflection items was associated with clinically signifi-
cant delusional improvements, but was not linked to
changes in hallucinations [47].
Our results should be considered in view of the limita-
tions of the study. Follow-up assessment occurred when
participants were willing to be interviewed, or when
clinical records were available, and so did not always
occur strictly within 4-year window. In terms of general-
isability, those participants missing at follow-up did have
significantly more severe psychopathology at baseline on
the GAF symptom measure than those participants
retained at follow-up. This may have caused some sam-
ple bias, but its effect on the strength of association with
BCIS measures is unclear. Evidence suggests that acute-
ness of psychosis at illness-onset predicts better symp-
tom outcomes [53], which means this study might be
underestimating the rates of positive recovery outcomes
[54]. Nevertheless, it seems unlikely that this identified
difference between those lost at follow-up and the
follow-up sample, impacted upon the main findings,
given that the baseline GAF symptom severity was not a
confounding variable in the regression model. Finally, it
is unfortunate that data on BCIS and JTC were not col-
lected at follow-up as it would have been useful to more
directly measure the stability of these constructs over
time.
Conclusion
Through employing a longitudinal design, we present
evidence that subjective self-reflection has an important
role in predicting symptom remission in early psychosis.
These findings reveal a potentially important target for
psychological intervention.
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